BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37189713)

  • 21. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
    Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
    Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
    Coutelier M; Goizet C; Durr A; Habarou F; Morais S; Dionne-Laporte A; Tao F; Konop J; Stoll M; Charles P; Jacoupy M; Matusiak R; Alonso I; Tallaksen C; Mairey M; Kennerson M; Gaussen M; Schule R; Janin M; Morice-Picard F; Durand CM; Depienne C; Calvas P; Coutinho P; Saudubray JM; Rouleau G; Brice A; Nicholson G; Darios F; Loureiro JL; Zuchner S; Ottolenghi C; Mochel F; Stevanin G
    Brain; 2015 Aug; 138(Pt 8):2191-205. PubMed ID: 26026163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDHD1, but Not DDHD2, Suppresses Neurite Outgrowth in SH-SY5Y and PC12 Cells by Regulating Protein Transport From Recycling Endosomes.
    Maemoto Y; Maruyama T; Nemoto K; Baba T; Motohashi M; Ito A; Tagaya M; Tani K
    Front Cell Dev Biol; 2020; 8():670. PubMed ID: 32850804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exome sequencing identifies novel compound heterozygous mutations in SPG11 that cause autosomal recessive hereditary spastic paraplegia.
    Zhao W; Zhu QY; Zhang JT; Liu H; Wang LJ; Chen ZQ; Guan LP; Huang XS; Yang L; Yu SY
    J Neurol Sci; 2013 Dec; 335(1-2):112-7. PubMed ID: 24090761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
    Klebe S; Depienne C; Gerber S; Challe G; Anheim M; Charles P; Fedirko E; Lejeune E; Cottineau J; Brusco A; Dollfus H; Chinnery PF; Mancini C; Ferrer X; Sole G; Destée A; Mayer JM; Fontaine B; de Seze J; Clanet M; Ollagnon E; Busson P; Cazeneuve C; Stevanin G; Kaplan J; Rozet JM; Brice A; Durr A
    Brain; 2012 Oct; 135(Pt 10):2980-93. PubMed ID: 23065789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation.
    Warnecke T; Duning T; Schwan A; Lohmann H; Epplen JT; Young P
    Neurology; 2007 Jul; 69(4):368-75. PubMed ID: 17646629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia.
    de Freitas JL; Rezende Filho FM; Sallum JMF; França MC; Pedroso JL; Barsottini OGP
    J Neurol Sci; 2020 Feb; 409():116620. PubMed ID: 31865189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms.
    Lo Giudice T; Lombardi F; Santorelli FM; Kawarai T; Orlacchio A
    Exp Neurol; 2014 Nov; 261():518-39. PubMed ID: 24954637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia.
    Gan-Or Z; Bouslam N; Birouk N; Lissouba A; Chambers DB; Vérièpe J; Androschuk A; Laurent SB; Rochefort D; Spiegelman D; Dionne-Laporte A; Szuto A; Liao M; Figlewicz DA; Bouhouche A; Benomar A; Yahyaoui M; Ouazzani R; Yoon G; Dupré N; Suchowersky O; Bolduc FV; Parker JA; Dion PA; Drapeau P; Rouleau GA; Ouled Amar Bencheikh B
    Am J Hum Genet; 2016 May; 98(5):1038-1046. PubMed ID: 27153400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14.
    Hodgkinson CA; Bohlega S; Abu-Amero SN; Cupler E; Kambouris M; Meyer BF; Bharucha VA
    Neurology; 2002 Dec; 59(12):1905-9. PubMed ID: 12499481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary spastic paraplegia.
    Roşulescu E; Stănoiu C; Buteică E; Stănoiu B; Burada F; Zăvăleanu M
    Rom J Morphol Embryol; 2009; 50(2):299-303. PubMed ID: 19434327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and management of hereditary spastic paraplegia.
    Faber I; Servelhere KR; Martinez AR; D'Abreu A; Lopes-Cendes I; França MC
    Arq Neuropsiquiatr; 2014 Mar; 72(3):219-26. PubMed ID: 24676440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new locus (SPG47) maps to 1p13.2-1p12 in an Arabic family with complicated autosomal recessive hereditary spastic paraplegia and thin corpus callosum.
    Blumkin L; Lerman-Sagie T; Lev D; Yosovich K; Leshinsky-Silver E
    J Neurol Sci; 2011 Jun; 305(1-2):67-70. PubMed ID: 21440262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis.
    Vantaggiato C; Panzeri E; Castelli M; Citterio A; Arnoldi A; Santorelli FM; Liguori R; Scarlato M; Musumeci O; Toscano A; Clementi E; Bassi MT
    Autophagy; 2019 Jan; 15(1):34-57. PubMed ID: 30081747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [AAA ATPases and hereditary spastic paraplegia].
    Wang YG; Shen L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):298-301. PubMed ID: 19504443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia.
    Zhao M; Chen YJ; Wang MW; Lin XH; Dong EL; Chen WJ; Wang N; Lin X
    Mol Diagn Ther; 2019 Dec; 23(6):781-789. PubMed ID: 31630374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel SPAST gene mutation identified in a Chinese family with hereditary spastic paraplegia.
    Yu W; Jin H; Deng J; Nan D; Huang Y
    BMC Med Genet; 2020 Jun; 21(1):123. PubMed ID: 32493220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4.
    Navas-Sánchez FJ; Fernández-Pena A; Martín de Blas D; Alemán-Gómez Y; Marcos-Vidal L; Guzmán-de-Villoria JA; Fernández-García P; Romero J; Catalina I; Lillo L; Muñoz-Blanco JL; Ordoñez-Ugalde A; Quintáns B; Pardo J; Sobrido MJ; Carmona S; Grandas F; Desco M
    J Neurol; 2021 Jul; 268(7):2429-2440. PubMed ID: 33507371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for Non-Mendelian Inheritance in Spastic Paraplegia 7.
    Estiar MA; Yu E; Haj Salem I; Ross JP; Mufti K; Akçimen F; Leveille E; Spiegelman D; Ruskey JA; Asayesh F; Dagher A; Yoon G; Tarnopolsky M; Boycott KM; Dupre N; Dion PA; Suchowersky O; Trempe JF; Rouleau GA; Gan-Or Z
    Mov Disord; 2021 Jul; 36(7):1664-1675. PubMed ID: 33598982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.